Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.96 USD | +7.72% | +8.53% | +229.02% |
05-31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
392M | - | - | - | - | - | |
739B | ||||||
598B | ||||||
353B | ||||||
318B | ||||||
285B |